Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.33
-0.08 (-1.48%)
Aug 10, 2026, 1:21 PM EDT - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $873.28 million as of August 10, 2026. Its market cap has increased by 237.27% in one year.
Market Cap
873.28M
Enterprise Value
673.69M
1-Year Change
237.27%
Ranking
Category
Stock Price
$5.33
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $873.28M, an increase of 36.55%. That is a compound annual growth rate of 5.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 873.28M | 16.71% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Omeros | 958.97M |
| Geron | 950.86M |
| Arbutus Biopharma | 914.60M |
| Aura Biosciences | 881.29M |
| Theravance Biopharma | 877.45M |
| Design Therapeutics | 875.52M |
| Kura Oncology | 849.57M |
| SpyGlass Pharma | 846.57M |